Drug intelligence / Profile preview

(S)-2-(mercaptomethyl)-5-phenylpentanoic acid

Development stage: Unknown
Modality: Small Molecules

Overview

(S)-2-(Mercaptomethyl)-5-phenylpentanoic acid is a small molecule organic compound classified as a medium-chain fatty acid derivative containing a mercaptomethyl group. It has the chemical formula C12H16O2S and an average molecular weight of approximately 224.3 g/mol. This compound is experimental and not approved for clinical use or marketed as a pharmaceutical drug. There is no available information on its mechanism of action, therapeutic indications, or clinical development status beyond being in an experimental phase with no registered clinical trials or approved uses.

Other names: (2S)-5-Phenyl-2-(sulfanylmethyl)pentanoic acidBenzenepentanoic acid, alpha-(mercaptomethyl)-(alphaS)M5PM-5PM 5P

Targets

VIM-2 (VIM-2 metallo-beta-lactamase)

Beyond the preview

Go deeper on (S)-2-(mercaptomethyl)-5-phenylpentanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (S)-2-(mercaptomethyl)-5-phenylpentanoic acid.

Explore the full profile